IMU 2.04% 4.8¢ imugene limited

If there was toxicity problem with azer-cel why would the FDA...

  1. 2,681 Posts.
    lightbulb Created with Sketch. 568
    If there was toxicity problem with azer-cel why would the FDA allow azer-cel to now be used with cf33?

    azer-cell was a long trial with a different company, precision biosciences. Now imugene will use their progress with cart-t to further our plan to get cf33 into patients.

    once again;

    https://hotcopper.com.au/attachments/asco-2021_preliminary-safety-and-efficacy-of-pbcar0191_page-0001-min-jpg.6284870/?temp_hash=69f1737579d6438e76e4fa37ad6d9f21
    Last edited by melburnian: 01/07/24
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
-0.001(2.04%)
Mkt cap ! $357.0M
Open High Low Value Volume
4.9¢ 4.9¢ 4.8¢ $279.2K 5.733M

Buyers (Bids)

No. Vol. Price($)
94 12992150 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 1795056 6
View Market Depth
Last trade - 16.10pm 28/10/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.